Global Insight Services has recently updated its global market reports, now including the latest data for 2024 and projections through 2033.
Parkinson’s Disease (PD) simply called as Parkinson’s, is a progressive neuro-degenerative disorder which mainly affects the motor systems due to the depletion in dopamine. The motor symptoms result from the death of cells in the substantia nigra leading to dopamine deficit. The cause of cell death involves the build-up of misfolded proteins into Lewy bodies in the neurons. Collectively known as Parkinsonian Syndrome.
View The Full Report Here –https://www.globalinsightservices.com/reports/parkinsons-disease-drug-pipeline-landscape/
The main cause of PD is not known. The environmental triggers, genetics are the associated factors in the cause of PD. Pesticides, herbicides and proximity to industrial plants, drugs are linked to the cause. The oxidation and generation of free radicals may be the cause of damage of thalamic nuclei.
The symptoms will slowly emerge. Early symptoms are tremors I hands, arms, legs and face, rigidity, slowness in the movement, difficulty walking, impaired balance and coordination. Other symptoms associated with cognitive and behavioural problems including depression, anxiety and apathy.
Parkinson’s disease is diagnosed based on medical history and also based on signs and symptoms. Single-photon emission computerized tomography (SPECT) scan and dopamine transporter (DAT) scan helps in determining the disease. Imaging tests including MRI, CT and PET scans also helps in diagnosing the disease.
The main goal is to reduce PD symptoms. Treatment includes medications, surgery and physical treatment. The drugs that are helps in treating motor symptoms are dopa decarboxylase inhibitors, COMT inhibitor, dopamine agonists and MAO-B inhibitors. Late-stage PD requires psychiatric treatment. In final stage palliative care should be provided to improve person’s quality of life.
Major pharmaceutical companies are involved in the development of potential drug candidates to improve the treatment of Parkinson’s Disease treatment such as ABBV-951, SPN-830, Buntanetap, E2027, and others. Key players involved in the development of therapies to treat Parkinson’s Disease are AbbVie, BenevolentAI, Novartis, Sumitomo Pharma and others. Two drugs are under late-stage Pre-registration, 30+ Phase III clinical trials and 10+ drugs are in Phase II clinical trials and some other drugs are under Phase I, preclinical and discovery stages of development.In Oct 2022, Supernus Pharmaceuticals Inc announced that the U.S. FDA has issued a complete Response Letter (CRL) for SPN-830 New Drug Application (NDA).
Request A Sample Of This Report –https://www.globalinsightservices.com/request-sample/GIS31241
Report Highlights
Global Insight Service’s, Parkinson’s Disease – Drug Pipeline Landscape, 2023 report provides an overview of the Parkinson’s Disease pipeline drugs. This report covers detailed insights on Parkinson’s Disease drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Parkinson’s Disease pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.
Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.
Scope
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.
Customise This Report As Per Your Requirements –https://www.globalinsightservices.com/request-customization/GIS31241
Report Segmentation
- Assessment by Stage of Development
- Assessment by Companies
- Assessment by Target
- Assessment by Mechanism of Action
- Assessment by Molecule Type
- Assessment by Route of Administration
Buy Now-https://www.globalinsightservices.com/checkout/single_user/GIS31241
Research Scope
- Scope – Highlights, Trends, Insights. Attractiveness, Forecast
- Market Sizing – Product Type, End User, Offering Type, Technology, Region, Country, Others
- Market Dynamics – Market Segmentation, Demand and Supply, Bargaining Power of Buyers and Sellers, Drivers, Restraints, Opportunities, Threat Analysis, Impact Analysis, Porters 5 Forces, Ansoff Analysis, Supply Chain
- Business Framework – Case Studies, Regulatory Landscape, Pricing, Policies and Regulations, New Product Launches. M&As, Recent Developments
- Competitive Landscape – Market Share Analysis, Market Leaders, Emerging Players, Vendor Benchmarking, Developmental Strategy Benchmarking, PESTLE Analysis, Value Chain Analysis
- Company Profiles – Overview, Business Segments, Business Performance, Product Offering, Key Developmental Strategies, SWOT Analysis.
With Global Insight Services, you receive:
10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Infographic excel data pack, easy to analyze big data
- Robust and transparent research methodology
- Unmatched data quality and after sales service
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.